By Kuda Pembere A clinical research study to assess the safety and efficacy of a new HIV vaccine is set to begin in Zimbabwe in May this year. The study will be coordinated across three sites: Mutala in Zimbabwe, the Desmond Tutu Health Foundation in Cape Town, and the Africa Health Research Institute in Durban. The research follows findings that countries in sub-Saharan Africa, including Zimbabwe and South Africa, face a high risk of new HIV infections and continue to experience unacceptably high rates of mother-to-child transmission. Speaking to nurses…
Read MoreZimbabwe to Begin HIV Vaccine Clinical Trial in May
